BC's Genome Sciences Center Lands $2.1M for New Sequencers | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – British Columbia has provided nearly C$2.2 million (US$2.1 million) to the BC Cancer Agency to buy three genome sequencers that will be installed in the Michael Smith Genome Sciences Centre (GSC).

Western Economic Diversification Canada (WD), which provided the funding, said on Friday that the program also will support a new business outreach coordinator who will aim to increase the GSC's work with industry.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: RNA-seq, ChIP-seq to determine metformin response; array-based approach to detect protozoa in blood; and more.

Fast Company takes a look at startups in the nutrigenomic space that aim to offer personalized diet advice.

In a glamorous event, the Breakthrough Foundation gave out more than $25 million in prizes to researchers.

Immunotherapy might treat cancer, but it also appears to come with a risk of a number of side effects, the New York Times reports.